AKTX vs ARWR
Akari Therapeutics PLC · Arrowhead Pharmaceuticals Inc
Relative return (rebased to 100)
Key stats
| Metric | AKTX | ARWR |
|---|---|---|
| Price | $10.70 | $81.65 |
| Market Cap | $1.67T | $11.53B |
| P/E | — | — |
| P/B | 89627.12 | 24.78 |
| P/S | 4530362.77 | 13.91 |
| ROE | -93.0% | -0.4% |
| Net Margin | -4702.1% | -0.2% |
| Gross Margin | — | — |
| Revenue Growth | -39.5% | 23258.2% |
| Dividend Yield | — | — |
| EPS | -$0.00 | -$0.01 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.